{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:24:51Z","timestamp":1782779091251,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T00:00:00Z","timestamp":1351209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00277-012-1611-2","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T03:46:50Z","timestamp":1351136810000},"page":"325-332","source":"Crossref","is-referenced-by-count":8,"title":["Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK\/T cell lymphoma, nasal type"],"prefix":"10.1007","volume":"92","author":[{"given":"Ting","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,26]]},"reference":[{"key":"1611_CR1","first-page":"285","volume-title":"World Health Organization Classification of Tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Quintanilla-Martinez L, Ferry JA et al (2008) Extranodal NK\/T-cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) World Health Organization Classification of Tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, pp 285\u2013288"},{"key":"1611_CR2","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T et al (2009) Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:3931\u20133937","journal-title":"Blood"},{"key":"1611_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<449::AID-CNCR13>3.0.CO;2-W","volume":"83","author":"YX Li","year":"1998","unstructured":"Li YX, Coucke PA, Li JY et al (1998) Primary non-Hodgkin\u2019s lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83:449\u2013456","journal-title":"Cancer"},{"key":"1611_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","volume":"54","author":"MM Cheung","year":"2002","unstructured":"Cheung MM, Chan JK, Lau WH et al (2002) Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182\u2013190","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","volume":"24","author":"YX Li","year":"2006","unstructured":"Li YX, Yao B, Jin J et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma. J Clin Oncol 24:181\u2013189","journal-title":"J Clin Oncol"},{"key":"1611_CR6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","volume":"41","author":"J Lee","year":"2005","unstructured":"Lee J, Park YH, Kim WS et al (2005) Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 41:1402\u20131408","journal-title":"Eur J Cancer"},{"key":"1611_CR7","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdn147","volume":"19","author":"TM Kim","year":"2008","unstructured":"Kim TM, Lee SY, Jeon YK et al (2008) Clinical heterogeneity of extranodal NK\/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 19:1477\u20131484","journal-title":"Ann Oncol"},{"key":"1611_CR8","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood-2008-05-160176","volume":"112","author":"YX Li","year":"2008","unstructured":"Li YX, Fang H, Liu QF et al (2008) Clinical features and treatment outcome of nasal-type NK\/T-cell lymphoma of Waldeyer ring. Blood 112:3057\u20133064","journal-title":"Blood"},{"key":"1611_CR9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","volume":"70","author":"MJ Huang","year":"2008","unstructured":"Huang MJ, Jiang Y, Liu WP et al (2008) Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 70:166\u2013174","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s12032-009-9288-7","volume":"27","author":"HH Ma","year":"2010","unstructured":"Ma HH, Qian LT, Pan HF et al (2010) Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer\/T-cell lymphoma. Med Oncol 27:798\u2013806","journal-title":"Med Oncol"},{"key":"1611_CR11","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-08-2914","volume":"15","author":"YX Li","year":"2009","unstructured":"Li YX, Liu QF, Fang H et al (2009) Variable clinical presentations of nasal and Waldeyer ring natural killer\/T-cell lymphoma. Clin Cancer Res 15:2905\u20132912","journal-title":"Clin Cancer Res"},{"key":"1611_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/02841869709001268","volume":"36","author":"K Sakata","year":"1997","unstructured":"Sakata K, Hareyama M, Ohuchi A et al (1997) Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 36:307\u2013311","journal-title":"Acta Oncol"},{"key":"1611_CR13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","volume":"100","author":"CC Li","year":"2004","unstructured":"Li CC, Tien HF, Tang JL et al (2004) Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma. Cancer 100:366\u2013375","journal-title":"Cancer"},{"key":"1611_CR14","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/cncr.26167","volume":"117","author":"YX Li","year":"2011","unstructured":"Li YX, Liu QF, Wang WH et al (2011) Failure patterns and clinical implications in early stage nasal natural killer\/T-cell lymphoma treated with primary radiotherapy. Cancer 117:5203\u20135211","journal-title":"Cancer"},{"key":"1611_CR15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.ijrobp.2010.10.040","volume":"82","author":"YX Li","year":"2012","unstructured":"Li YX, Wang H, Jin J et al (2012) Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK\/T-cell lymphoma. Int J Radiat Oncol Biol Phys 82:1809\u20131815","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","volume":"18","author":"GE Kim","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI et al (2000) Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 18:54\u201363","journal-title":"J Clin Oncol"},{"key":"1611_CR17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","volume":"103","author":"CS Chim","year":"2004","unstructured":"Chim CS, Ma SY, Au WY et al (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103:216\u2013221","journal-title":"Blood"},{"key":"1611_CR18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/annonc\/mdh143","volume":"15","author":"JY You","year":"2004","unstructured":"You JY, Chi KH, Yang MH et al (2004) Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)\/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 15:618\u2013625","journal-title":"Ann Oncol"},{"key":"1611_CR19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/annonc\/mdn551","volume":"20","author":"BS Kim","year":"2009","unstructured":"Kim BS, Kim DW, Im SA et al (2009) Effective second-line chemotherapy for extranodal NK\/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Ann Oncol 20:121\u2013128","journal-title":"Ann Oncol"},{"key":"1611_CR20","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29:4410\u20134416","journal-title":"J Clin Oncol"},{"key":"1611_CR21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","volume":"117","author":"A Jaccard","year":"2011","unstructured":"Jaccard A, Gachard N, Marin B et al (2011) Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study. Blood 117:1834\u20131839","journal-title":"Blood"},{"key":"1611_CR22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2008.08.066","volume":"74","author":"XX Zhang","year":"2009","unstructured":"Zhang XX, Xie CH, Xu Y et al (2009) Salvage treatment improved survival of patients with relapsed extranodal natural killer\/t-cell lymphoma, nasal type. Int J Radiat Oncol Biol Phys 74:747\u2013752","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR23","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","volume":"82","author":"H Wang","year":"2012","unstructured":"Wang H, Li YX, Wang WH et al (2012) Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early stage nasal NK\/T-cell lymphoma. Int J Radiat Oncol Biol Phys 82:1115\u20131121","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. J Clin Oncol 17:1244\u20131253","journal-title":"J Clin Oncol"},{"key":"1611_CR25","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3109\/10428194.2011.634040","volume":"53","author":"SN Qi","year":"2012","unstructured":"Qi SN, Li YX, Wang WH et al (2012) The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer\/T-cell lymphoma with cutaneous secondary involvement. Leuk Lymphoma 53:855\u2013861","journal-title":"Leuk Lymphoma"},{"key":"1611_CR26","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","volume":"114","author":"ZY Wang","year":"2009","unstructured":"Wang ZY, Li YX, Wang WH et al (2009) Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents. Blood 114:4771\u20134776","journal-title":"Blood"},{"key":"1611_CR27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2010.02.023","volume":"80","author":"AM Chen","year":"2011","unstructured":"Chen AM, Farwell DG, Luu Q et al (2011) Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. Int J Radiat Oncol Biol Phys 80:669\u2013676","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1611_CR28","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1002\/cncr.25305","volume":"116","author":"DJ Cher","year":"2010","unstructured":"Cher DJ, Haddad RI, Norris CM et al (2010) Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 116:4761\u20134768","journal-title":"Cancer"},{"key":"1611_CR29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00277-008-0669-3","volume":"88","author":"W Yong","year":"2009","unstructured":"Yong W, Zheng W, Zhu J et al (2009) L-Asparaginase in the treatment of refractory and relapsed extranodal NK\/T-cell lymphoma, nasal type. Ann Hematol 88:647\u2013652","journal-title":"Ann Hematol"},{"key":"1611_CR30","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/10428190600562823","volume":"47","author":"KW Lee","year":"2006","unstructured":"Lee KW, Yun T, Kim DW et al (2006) First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy\u2009\u00b1\u2009radiotherapy is active in stage I\/II extranodal NK\/T-cell lymphoma. Leuk Lymphoma 47:1274\u20131282","journal-title":"Leuk Lymphoma"},{"key":"1611_CR31","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3109\/10428194.2011.561388","volume":"52","author":"HQ Huang","year":"2011","unstructured":"Huang HQ, Lin ZX, Lin XB et al (2011) Long-term outcomes of patients with newly diagnosed extranodal natural killer\/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leuk Lymphoma 52:1041\u20131048","journal-title":"Leuk Lymphoma"},{"key":"1611_CR32","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","volume":"27","author":"SJ Kim","year":"2009","unstructured":"Kim SJ, Kim K, Kim BS et al (2009) Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival Of Lymphoma study. J Clin Oncol 27:6027\u20136032","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1611-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1611-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1611-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:50:28Z","timestamp":1559037028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1611-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,26]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1611"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1611-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,26]]}}}